Aethlon Medical (AEMD) Long-Term Deferred Tax (2015 - 2026)

Aethlon Medical's Long-Term Deferred Tax history runs 12 years deep, the most recent figure standing at $36.6 million for Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax rose 6.54% year-over-year to $36.6 million; the trailing twelve-month figure through Mar 2026 stood at $36.6 million (up 6.54% YoY), and the FY2026 full-year result was $36.6 million, up 6.54% from the prior year.
• Long-Term Deferred Tax was $36.6 million for Q1 2026 at Aethlon Medical, up from $34.4 million in the prior quarter.
• Over the last five years, Long-Term Deferred Tax for AEMD reached as high as $36.6 million in Q1 2026 and fell as low as $27.1 million in Q1 2022.
• Median Long-Term Deferred Tax over the past 5 years was $33.3 million (2024), compared with a mean of $32.3 million.
• Across the five-year window, Long-Term Deferred Tax climbed 10.82% in 2023 and rose 3.42% in 2025, its largest moves.
• Over 5 years, Long-Term Deferred Tax stood at $27.1 million in 2022, then advanced by 10.82% to $30.0 million in 2023, then advanced by 10.78% to $33.3 million in 2024, then climbed by 3.42% to $34.4 million in 2025, then grew by 6.54% to $36.6 million in 2026.
• Business Quant data shows AEMD's Long-Term Deferred Tax at $36.6 million in Q1 2026, $34.4 million in Q1 2025, and $33.3 million in Q1 2024.